Finerenone and new-onset diabetes in heart failure: a prespecified analysis of the FINEARTS-HF trial
Butt JH, Jhund PS, Henderson AD, et al.
Lancet Diabetes Endocrinol. Pub. online 13 Jan 2025.
Leggi
Unexpected cardiovascular risks of glucagon-like peptide-1 receptor agonist and aspirin co-administration in individuals with obesity, with and without type 2 diabetes: A propensity score matched cohort study
Lin CM, Chen JC, Meyerowitz-Katz G, et al.
Diabetes Obes Metab. Pub. online 13 Jan 2025.
Leggi
Effects of novel antidiabetic agents on contrast-associated acute kidney injury in diabetic patients undergoing percutaneous coronary intervention
Nusca A, Di Bitonto MP, Spanò A, et al.
Am J Cardiol. 2025:S0002-9149(25)00015-3.
Leggi
Sugar-sweetened or artificially sweetened beverage consumption, physical activity and risk of type 2 diabetes in US adults
Pacheco LS, Tobias DK, Haslam DE, et al.
Diabetologia. Pub. online 8 Jan 2025.
Leggi
Real-world retrospective study in elderly patients aged 65 years and older with type 2 diabetes mellitus treated with daily oral semaglutide (SEMA-elderly)
Fiore V, Carbotta G, Barraco S, et al.
Diabetes Obes Metab. Pub. online 10 Jan 2025.
Leggi
Understanding the relationship between the frequency of HbA1c monitoring, HbA1c changes over time, and the achievement of targets: a retrospective cohort study
Mukonda E, van der Westhuizen DJ, Dave JA, et al.
BMC Endocr Disord. 2025;25(1):3.
Leggi
Trends and analysis of risk factor differences in the global burden of chronic kidney disease due to type 2 diabetes from 1990 to 2021: A population-based study
Wang Y, Lin T, Lu J, et al.
Diabetes Obes Metab. Pub. online 13 Jan 2025.
Leggi
ANNALI AMD – “Analisi predittiva con Machine Learning – Pazienti con DMT2 trattati con analoghi del GLP1: probabilità di andare a target entro 1 anno dall’intensificazione con insulina”
Carissimi Soci, siamo lieti di condividere il report dell’analisi condotta con strumenti di machine learning, messo a punto dal Gruppo Intelligenza Artificiale e basato sui dati degli Annali AMD: “Analisi predittiva - Pazienti con diabete tipo 2 trattati con analoghi del GLP1: probabilità di andare a target entro 1 anno dall’intensificazione con insulina”.…
Leggi
Socioeconomic and mental health inequalities in global burden of type 2 diabetes: Evidence from the Global Burden of Disease Study 2021
Chen M, Dou C, Ye C, et al.
Diabetes Obes Metab. Pub. online 6 Jan 2025.
Leggi